.png)
Alopecia Treatment Market By Disease Type, Treatment Type and End User - Global Industry Analysis & Forecast to 2027
Published On : August 2018 Pages : 175 Category: Pharmaceuticals Report Code : CM081156
SEGMENTS & REGIONS:
- Regions: North America, Europe, Asia- Pacific, Latin America, Middle East & Africa
Industry Outlook and Trend Analysis
The Alopecia Treatment Market has encountered significant development in the recent years and is anticipated to grow tremendously over the forecast period. Alopecia also recognized as hair-loss or baldness is a medicinal condition that alludes to loss of hairs from head or any part of the body. The condition can happen in both male and female and at any age. There are five main kind of alopecia to be specific; androgenic alopecia, ciatricial alopecia, androgenic alopecia, alopecia totalis, and traction alopecia. Alopecia areata is a typical autoimmune disorder in which the safe arrangement of body assaults the sound hair follicle prompting hair fall. Development of the alopecia treatment market is fundamentally determined by expanding interest for hair loss treatment drugs with improved viability and insignificant reactions. For instance, as of late cytokine therapy too regenerative cell treatment is picking up demand for treatment of different sorts of alopecia. Treatment with cytokine treatment have expanded capacity in hair regrowth bringing about hair follicle cells to get differenced and multiplied while controlling hair growth cycle.
Disease Type Outlook and Trend Analysis
Increasing pervasiveness of alopecia areata has been developing essentially over the years credited to expanding predominance of different dermatology related skin issue. On the basis of value, alopecia areata fragment is evaluated to represent a major share of the market over the forecast period. The fragment is anticipated to pick up traction owing to increasing awareness over the forecast period.
Treatment Type Outlook and Trend Analysis
Topical medications incorporates lotions, gels, creams, foam, and shampoos, while the injectable treatment compose section incorporates steroids, platelet rich plasma therapy, and injectable fillers. Propecia, an oral drug is at present the main FDA affirmed medication in treatment of alopecia. Restricted clinical efficacy exhibited by such medicines would hamper market and income development of established products over the figure time frame.
End User Outlook and Trend Analysis
Dermatology and trichology clinics section is the most elevated income supporter of the alopecia treatment market trailed by home care settings and end user portions. Over the counter distribution and rising level of e-Commerce implementation is anticipated to prompt expanded selection of topical hair loss treatments in home care settings.
Regional Outlook and Trend Analysis
North America, trailed by Europe, is foreseen to overwhelm the alopecia treatment market all through the conjecture time frame. Asia Pacific is anticipated to witness speediest development attributable to upheaval of middle aged populace in the area. Likewise, the district is observing sound development as far as GDP, which is anticipated to move development at solid digits. Middle East and Africa and Latin America are foreseen to encounter sluggish development amid the conjecture time frame.
Competitive Insights
The leading players in the market are Ranbaxy Laboratories, Dr. Reddy's Laboratories, Nanogen, Merck & Co, Vitabiotics, Viviscal, Kirkland Signature, Cipla, Phyto - Alès Groupe and Johnson and Johnson. The major players in the market are profiled in detail in view of qualities, for example, company portfolio, business strategies, financial overview, recent developments, and share of the overall industry.
The Alopecia Treatment Market is segmented based on regions as follows-
By Region
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- UK
- France
- Russia
- Italy
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Southeast Asia
- Rest of Asia-Pacific
- South America
- Brazil
- Argentina
- Columbia
- Rest of South America
- Middle East and Africa
- Saudi Arabia
- UAE
- Egypt
- Nigeria
- South Africa
- Rest of MEA
Some of the key questions answered by the report are:
- What was the market size in 2017 and forecast from 2017 to 2027?
- What will be the industry market growth from 2017 to 2027?
- What are the major drivers, restraints, opportunities, challenges, and industry trends and their impact on the market forecast?
- What are the major segments leading the market growth and why?
- Which are the leading players in the market and what are the major strategies adopted by them to sustain the market competition?
Market Classification
· Alopecia Treatment, By Disease Type, Estimates and Forecast, 2017-2027($Billion)
o Androgenic Alopecia
o Ciatricial Alopecia
o Alopecia Areata
o Traction Alopecia
o Alopecia Totalis
· Alopecia Treatment, By Treatment Type, Estimates and Forecast, 2017-2027($Billion)
o Topical Drugs
o Injectable
o Low Level Laser Therapy
o Oral Drugs
o Hair Transplant Services
· Alopecia Treatment, By End User, Estimates and Forecast, 2017-2027($Billion)
o Homecare Settings
o Dermatology Clinics
o Others
· Alopecia Treatment, By Region, Estimates and Forecast, 2017-2027($Billion)
o North America
§ North America Alopecia Treatment, By Country
o U.S. Alopecia Treatment
o Canada Alopecia Treatment
o Mexico Alopecia Treatment
o Europe
§ Europe Alopecia Treatment, By Country
o Germany Alopecia Treatment
o UK Alopecia Treatment
o France Alopecia Treatment
o Russia Alopecia Treatment
o Italy Alopecia Treatment
o Rest of Europe Alopecia Treatment
o Asia-Pacific
§ Asia-Pacific Alopecia Treatment, By Country
o China Alopecia Treatment
o Japan Alopecia Treatment
o South Korea Alopecia Treatment
o India Alopecia Treatment
o Southeast Asia Alopecia Treatment
o Rest of Asia-Pacific Alopecia Treatment
o South America
§ South America Alopecia Treatment
o Brazil Alopecia Treatment
o Argentina Alopecia Treatment
o Columbia Alopecia Treatment
o Rest of South America Alopecia Treatment
o Middle East and Africa
§ Middle East and Africa Alopecia Treatment
o Saudi Arabia Alopecia Treatment
o UAE Alopecia Treatment
o Egypt Alopecia Treatment
o Nigeria Alopecia Treatment
o South Africa Alopecia Treatment
o Rest of MEA Alopecia Treatment
Table of Contents
1. Introduction
1.1. Report Description
2. Executive Summary
2.1. Key Highlights
3. Market Overview
3.1. Introduction
3.1.1. Market Definition
3.1.2. Market Segmentation
3.2. Market Dynamics
3.2.1. Drivers
3.2.2. Restraints
3.2.3. Opportunities
4. Market Analysis by Regions
4.1. North America (United States, Canada and Mexico)
4.1.1. United States Market Status and Outlook (2017-2027)
4.1.2. Canada Market Status and Outlook (2017-2027)
4.1.3. Mexico Market Status and Outlook (2017-2027)
4.2. Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
4.2.1. Germany Market Status and Outlook (2017-2027)
4.2.2. France Market Status and Outlook (2017-2027)
4.2.3. UK Market Status and Outlook (2017-2027)
4.2.4. Russia Market Status and Outlook (2017-2027)
4.2.5. Italy Market Status and Outlook (2017-2027)
4.2.6. Rest of Europe Market Status and Outlook (2017-2027)
4.3. Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Rest of Asia-Pacific)
4.3.1. China Market Status and Outlook (2017-2027)
4.3.2. Japan Market Status and Outlook (2017-2027)
4.3.3. Korea Market Status and Outlook (2017-2027)
4.3.4. India Market Status and Outlook (2017-2027)
4.3.5. Southeast Asia Market Status and Outlook (2017-2027)
4.3.6. Rest of Asia-Pacific Market Status and Outlook (2017-2027)
4.4. South America (Brazil, Argentina, Columbia and Rest of South America)
4.4.1. Brazil Market Status and Outlook (2017-2027)
4.4.2. Argentina Market Status and Outlook (2017-2027)
4.4.3. Columbia Market Status and Outlook (2017-2027)
4.4.4. Rest of South America Market Status and Outlook (2017-2027)
4.5. Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa and Rest of MEA)
4.5.1. Saudi Arabia Market Status and Outlook (2017-2027)
4.5.2. United Arab Emirates Market Status and Outlook (2017-2027)
4.5.3. Egypt Market Status and Outlook (2017-2027)
4.5.4. Nigeria Market Status and Outlook (2017-2027)
4.5.5. South Africa Market Status and Outlook (2017-2027)
4.5.6. Turkey Market Status and Outlook (2017-2027)
4.5.7. Rest of Middle East and Africa Market Status and Outlook (2017-2027)
5. Alopecia Treatment Market, By Disease Type
5.1. Introduction
5.2. Global Alopecia Treatment Revenue and Market Share by Disease Type (2017-2027)
5.2.1. Global Alopecia Treatment Revenue and Revenue Share by Disease Type (2017-2027)
5.3. Androgenic Alopecia
5.3.1. Global Androgenic Alopecia Revenue and Growth Rate (2017-2027)
5.4. Ciatricial Alopecia
5.4.1. Global Ciatricial Alopecia Revenue and Growth Rate (2017-2027)
5.5. Alopecia Areata
5.5.1. Global Alopecia Areata Revenue and Growth Rate (2017-2027)
5.6. Traction Alopecia
5.6.1. Global Traction Alopecia Revenue and Growth Rate (2017-2027)
5.7. Alopecia Totalis
5.7.1. Global Alopecia Totalis Revenue and Growth Rate (2017-2027)
6. Alopecia Treatment Market, By Treatment Type
6.1. Introduction
6.2. Global Alopecia Treatment Revenue and Market Share by Treatment Type (2017-2027)
6.2.1. Global Alopecia Treatment Revenue and Revenue Share by Treatment Type (2017-2027)
6.3. Topical Drugs
6.3.1. Global Topical Drugs Revenue and Growth Rate (2017-2027)
6.4. Injectable
6.4.1. Global Injectable Revenue and Growth Rate (2017-2027)
6.5. Low Level Laser Therapy
6.5.1. Global Low Level Laser Therapy Revenue and Growth Rate (2017-2027)
6.6. Oral Drugs
6.6.1. Global Oral Drugs Revenue and Growth Rate (2017-2027)
6.7. Hair Transplant Services
6.7.1. Global Hair Transplant Services Revenue and Growth Rate (2017-2027)
7. Alopecia Treatment Market, By End User
7.1. Introduction
7.2. Global Alopecia Treatment Revenue and Market Share by End User (2017-2027)
7.2.1. Global Alopecia Treatment Revenue and Revenue Share by End User (2017-2027)
7.3. Homecare Settings
7.3.1. Global Homecare Settings Revenue and Growth Rate (2017-2027)
7.4. Dermatology Clinics
7.4.1. Global Dermatology Clinics Revenue and Growth Rate (2017-2027)
7.5. Others
7.5.1. Global Others Revenue and Growth Rate (2017-2027)
8. Alopecia Treatment Market, By Region
8.1. Introduction
8.2. Global Alopecia Treatment Revenue and Market Share by Regions
8.2.1. Global Alopecia Treatment Revenue by Regions (2017-2027)
8.3. North America Alopecia Treatment by Countries
8.3.1. North America Alopecia Treatment Revenue and Growth Rate (2017-2027)
8.3.2. North America Alopecia Treatment Revenue (Million USD) by Countries (2017-2027)
8.3.3. United States
8.3.3.1. United States Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.4. Canada
8.3.4.1. Canada Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.3.5. Mexico
8.3.5.1. Mexico Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4. Europe Alopecia Treatment by Countries
8.4.1. Europe Alopecia Treatment Revenue and Growth Rate (2017-2027)
8.4.2. Europe Alopecia Treatment Revenue (Million USD) by Countries (2017-2027)
8.4.3. Germany
8.4.3.1. Germany Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.4. France
8.4.4.1. France Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.5. UK
8.4.5.1. UK Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.6. Russia
8.4.6.1. Russia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.7. Italy
8.4.7.1. Italy Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.4.8. Rest of Europe
8.4.8.1. Rest of Europe Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5. Asia-Pacific Alopecia Treatment by Countries
8.5.1. Asia-Pacific Alopecia Treatment Revenue and Growth Rate (2017-2027)
8.5.2. Asia-Pacific Alopecia Treatment Revenue (Million USD) by Countries (2017-2027)
8.5.3. China
8.5.3.1. China Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.4. Japan
8.5.4.1. Japan Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.5. Korea
8.5.5.1. Korea Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.6. India
8.5.6.1. India Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.7. Southeast Asia
8.5.7.1. Southeast Asia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.5.8. Rest of Asia-Pacific
8.5.8.1. Rest of Asia-Pacific Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6. South America Alopecia Treatment by Countries
8.6.1. South America Alopecia Treatment Revenue and Growth Rate (2017-2027)
8.6.2. South America Alopecia Treatment Revenue (Million USD) by Countries (2017-2027)
8.6.3. Brazil
8.6.3.1. Brazil Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.4. Argentina
8.6.4.1. Argentina Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.5. Columbia
8.6.5.1. Columbia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.6.6. Rest of South America
8.6.6.1. Rest of South America Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7. Middle East and Africa Alopecia Treatment by Countries
8.7.1. Middle East and Africa Alopecia Treatment Revenue and Growth Rate (2017-2027)
8.7.2. Middle East and Africa Alopecia Treatment Revenue (Million USD) by Countries (2017-2027)
8.7.3. Saudi Arabia
8.7.3.1. Saudi Arabia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.4. United Arab Emirates
8.7.4.1. United Arab Emirates Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.5. Egypt
8.7.5.1. Egypt Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.6. Nigeria
8.7.6.1. Nigeria Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.7. South Africa
8.7.7.1. South Africa Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.8. Turkey
8.7.8.1. Turkey Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
8.7.9. Rest of Middle East and Africa
8.7.9.1. Rest of Middle East and Africa Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
9. Company Profiles
9.1. Aclaris Therapeutics, Inc.
9.1.1. Business Overview
9.1.2. Service Portfolio
9.1.3. Strategic Developments
9.1.4. Financial Overview
9.2. HCell Inc.
9.2.1. Business Overview
9.2.2. Service Portfolio
9.2.3. Strategic Developments
9.2.4. Financial Overview
9.3. Histogen, Inc.
9.3.1. Business Overview
9.3.2. Service Portfolio
9.3.3. Strategic Developments
9.3.4. Financial Overview
9.4. Concert Pharmaceuticals, Inc.
9.4.1. Business Overview
9.4.2. Service Portfolio
9.4.3. Strategic Developments
9.4.4. Financial Overview
9.5. Daiichi Sankyo, Inc.
9.5.1. Business Overview
9.5.2. Service Portfolio
9.5.3. Strategic Developments
9.5.4. Financial Overview
9.6. GlaxoSmithKline plc.
9.6.1. Business Overview
9.6.2. Service Portfolio
9.6.3. Strategic Developments
9.6.4. Financial Overview
9.7. Cipla Limited
9.7.1. Business Overview
9.7.2. Service Portfolio
9.7.3. Strategic Developments
9.7.4. Financial Overview
9.8. Dr. Reddy’s Laboratories
9.8.1. Business Overview
9.8.2. Service Portfolio
9.8.3. Strategic Developments
9.8.4. Financial Overview
9.9. Vitabiotics
9.9.1. Business Overview
9.9.2. Service Portfolio
9.9.3. Strategic Developments
9.9.4. Financial Overview
9.10. Phyto Ales Group
9.10.1. Business Overview
9.10.2. Service Portfolio
9.10.3. Strategic Developments
9.10.4. Financial Overview
9.11. Johnson & Johnson
9.11.1. Business Overview
9.11.2. Service Portfolio
9.11.3. Strategic Developments
9.11.4. Financial Overview
9.12. Alpecin
9.12.1. Business Overview
9.12.2. Service Portfolio
9.12.3. Strategic Developments
9.12.4. Financial Overview
10. Alopecia Treatment Market Forecast (2017-2027)
10.1. Global Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2027)
10.2. Alopecia Treatment Market Forecast by Regions (2017-2027)
10.2.1. North America Alopecia Treatment Market Forecast (2017-2027)
10.2.1.1. United States Alopecia Treatment Market Forecast (2017-2027)
10.2.1.2. Canada Alopecia Treatment Market Forecast (2017-2027)
10.2.1.3. Mexico Alopecia Treatment Market Forecast (2017-2027)
10.2.2. Europe Alopecia Treatment Market Forecast (2017-2027)
10.2.2.1. Germany Alopecia Treatment Market Forecast (2017-2027)
10.2.2.2. France Alopecia Treatment Market Forecast (2017-2027)
10.2.2.3. UK Alopecia Treatment Market Forecast (2017-2027)
10.2.2.4. Russia Alopecia Treatment Market Forecast (2017-2027)
10.2.2.5. Italy Alopecia Treatment Market Forecast (2017-2027)
10.2.2.6. Rest of Europe Alopecia Treatment Market Forecast (2017-2027)
10.2.3. Asia-Pacific Alopecia Treatment Market Forecast (2017-2027)
10.2.3.1. China Alopecia Treatment Market Forecast (2017-2027)
10.2.3.2. Japan Alopecia Treatment Market Forecast (2017-2027)
10.2.3.3. Korea Alopecia Treatment Market Forecast (2017-2027)
10.2.3.4. India Alopecia Treatment Market Forecast (2017-2027)
10.2.3.5. Southeast Asia Alopecia Treatment Market Forecast (2017-2027)
10.2.3.6. Rest of Asia-Pacific Alopecia Treatment Market Forecast (2017-2027)
10.2.4. South America Alopecia Treatment Market Forecast (2017-2027)
10.2.4.1. Brazil Alopecia Treatment Market Forecast (2017-2027)
10.2.4.2. Argentina Alopecia Treatment Market Forecast (2017-2027)
10.2.4.3. Columbia Alopecia Treatment Market Forecast (2017-2027)
10.2.4.4. Rest of South America Alopecia Treatment Market Forecast (2017-2027)
10.2.5. Middle East and Africa Alopecia Treatment Market Forecast (2017-2027)
10.2.5.1. Saudi Arabia Alopecia Treatment Market Forecast (2017-2027)
10.2.5.2. United Arab Emirates Alopecia Treatment Market Forecast (2017-2027)
10.2.5.3. Egypt Alopecia Treatment Market Forecast (2017-2027)
10.2.5.4. Nigeria Alopecia Treatment Market Forecast (2017-2027)
10.2.5.5. South Africa Alopecia Treatment Market Forecast (2017-2027)
10.2.5.6. Turkey Alopecia Treatment Market Forecast (2017-2027)
10.2.5.7. Rest of Middle East and Africa Alopecia Treatment Market Forecast (2017-2027)
10.3. Alopecia Treatment Market Forecast by Disease Type (2017-2027)
10.3.1. Alopecia Treatment Forecast by Disease Type (2017-2027)
10.3.2. Alopecia Treatment Market Share Forecast by Disease Type (2017-2027)
10.4. Alopecia Treatment Market Forecast by Treatment Type (2017-2027)
10.4.1. Alopecia Treatment Forecast by Treatment Type (2017-2027)
10.4.2. Alopecia Treatment Market Share Forecast by Treatment Type (2017-2027)
10.5. Alopecia Treatment Market Forecast by End User (2017-2027)
10.5.1. Alopecia Treatment Forecast by End User (2017-2027)
10.5.2. Alopecia Treatment Market Share Forecast by End User (2017-2027)
List of Tables
Figure United States Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Canada Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Mexico Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Germany Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure France Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure UK Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Russia Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Italy Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Europe Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure China Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Japan Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Korea Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure India Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Southeast Asia Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Asia-Pacific Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Brazil Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Argentina Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Columbia Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of South America Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Saudi Arabia Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure United Arab Emirates Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Egypt Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Nigeria Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure South Africa Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Turkey Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Figure Rest of Middle East and Africa Alopecia Treatment Revenue (Million USD) and Growth Rate (2017-2025)
Table Global Alopecia Treatment Revenue and Revenue Share by Disease Type (2017-2018)
Figure Global Androgenic Alopecia Revenue and Growth Rate (2017-2018)
Figure Global Ciatricial Alopecia Revenue and Growth Rate (2017-2018)
Figure Global Alopecia Areata Revenue and Growth Rate (2017-2018)
Figure Global Traction Alopecia Revenue and Growth Rate (2017-2018)
Figure Global Alopecia Totalis Revenue and Growth Rate (2017-2018)
Table Global Alopecia Treatment Revenue and Revenue Share by Treatment Type (2017-2018)
Figure Global Topical Drugs Revenue and Growth Rate (2017-2018)
Figure Global Injectable Revenue and Growth Rate (2017-2018)
Figure Global Low Level Laser Therapy Revenue and Growth Rate (2017-2018)
Figure Global Oral Drugs Revenue and Growth Rate (2017-2018)
Figure Global Hair Transplant Services Revenue and Growth Rate (2017-2018)
Table Global Alopecia Treatment Revenue and Revenue Share by End User (2017-2018)
Figure Global Homecare Settings Revenue and Growth Rate (2017-2018)
Figure Global Dermatology Clinics Revenue and Growth Rate (2017-2018)
Figure Global Others Revenue and Growth Rate (2017-2018)
Table Global Alopecia Treatment Revenue by Regions (2017-2018)
Figure North America Alopecia Treatment Growth Rate (2017-2018)
Figure North America Alopecia Treatment Revenue and Growth Rate (2017-2018)
Figure North America Alopecia Treatment by Countries (2017-2018)
Figure North America Alopecia Treatment Revenue (Million USD) by Countries (2017-2018)
Figure United States Alopecia Treatment Growth Rate (2017-2018)
Figure United States Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Canada Alopecia Treatment Growth Rate (2017-2018)
Figure Canada Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Mexico Alopecia Treatment Growth Rate (2017-2018)
Figure Mexico Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Europe Alopecia Treatment Growth Rate (2017-2018)
Figure Europe Alopecia Treatment Revenue and Growth Rate (2017-2018)
Figure Europe Alopecia Treatment by Countries (2017-2018)
Figure Europe Alopecia Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Germany Alopecia Treatment Growth Rate (2017-2018)
Figure Germany Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure France Alopecia Treatment Growth Rate (2017-2018)
Figure France Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure UK Alopecia Treatment Growth Rate (2017-2018)
Figure UK Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Russia Alopecia Treatment Growth Rate (2017-2018)
Figure Russia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Italy Alopecia Treatment Growth Rate (2017-2018)
Figure Italy Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Europe Alopecia Treatment Growth Rate (2017-2018)
Figure Rest of Europe Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Asia-Pacific Alopecia Treatment Growth Rate (2017-2018)
Figure Asia-Pacific Alopecia Treatment Revenue and Growth Rate (2017-2018)
Figure Asia-Pacific Alopecia Treatment by Countries (2017-2018)
Figure Asia-Pacific Alopecia Treatment Revenue (Million USD) by Countries (2017-2018)
Figure China Alopecia Treatment Growth Rate (2017-2018)
Figure China Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Japan Alopecia Treatment Growth Rate (2017-2018)
Figure Japan Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Korea Alopecia Treatment Growth Rate (2017-2018)
Figure Korea Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure India Alopecia Treatment Growth Rate (2017-2018)
Figure India Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Southeast Asia Alopecia Treatment Growth Rate (2017-2018)
Figure Southeast Asia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Alopecia Treatment Growth Rate (2017-2018)
Figure Rest of Asia-Pacific Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South America Alopecia Treatment Growth Rate (2017-2018)
Figure South America Alopecia Treatment Revenue and Growth Rate (2017-2018)
Figure South America Alopecia Treatment by Countries (2017-2018)
Figure South America Alopecia Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Brazil Alopecia Treatment Growth Rate (2017-2018)
Figure Brazil Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Argentina Alopecia Treatment Growth Rate (2017-2018)
Figure Argentina Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Columbia Alopecia Treatment Growth Rate (2017-2018)
Figure Columbia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of South America Alopecia Treatment Growth Rate (2017-2018)
Figure Rest of South America Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Middle East and Africa Alopecia Treatment Growth Rate (2017-2018)
Figure Middle East and Africa Alopecia Treatment Revenue and Growth Rate (2017-2018)
Figure Middle East and Africa Alopecia Treatment by Countries (2017-2018)
Figure Middle East and Africa Alopecia Treatment Revenue (Million USD) by Countries (2017-2018)
Figure Saudi Arabia Alopecia Treatment Growth Rate (2017-2018)
Figure Saudi Arabia Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure United Arab Emirates Alopecia Treatment Growth Rate (2017-2018)
Figure United Arab Emirates Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Egypt Alopecia Treatment Growth Rate (2017-2018)
Figure Egypt Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Nigeria Alopecia Treatment Growth Rate (2017-2018)
Figure Nigeria Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure South Africa Alopecia Treatment Growth Rate (2017-2018)
Figure South Africa Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Turkey Alopecia Treatment Growth Rate (2017-2018)
Figure Turkey Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Alopecia Treatment Growth Rate (2017-2018)
Figure Rest of Middle East and Africa Alopecia Treatment Revenue (Millions USD) and Growth Rate (2017-2018)
Table Aclaris Therapeutics, Inc. Alopecia Treatment Financial Overview
Table HCell Inc. Alopecia Treatment Financial Overview
Table Histogen, Inc. Alopecia Treatment Financial Overview
Table Concert Pharmaceuticals, Inc. Alopecia Treatment Financial Overview
Table Daiichi Sankyo, Inc. Alopecia Treatment Financial Overview
Table GlaxoSmithKline plc. Alopecia Treatment Financial Overview
Table Cipla Limited Alopecia Treatment Financial Overview
Table Dr. Reddy’s Laboratories Alopecia Treatment Financial Overview
Table Vitabiotics Alopecia Treatment Financial Overview
Table Phyto Ales Group Alopecia Treatment Financial Overview
Table Johnson & Johnson Alopecia Treatment Financial Overview
Table Alpecin Alopecia Treatment Financial Overview
Figure Global Alopecia Treatment Revenue (Millions USD) and Growth Rate (2018-2025)
Table Alopecia Treatment Market Forecast by Regions (2018-2025)
Figure North America Alopecia Treatment Market Forecast (2018-2025)
Figure United States Alopecia Treatment Market Forecast (2018-2025)
Figure Canada Alopecia Treatment Market Forecast (2018-2025)
Figure Mexico Alopecia Treatment Market Forecast (2018-2025)
Figure Europe Alopecia Treatment Market Forecast (2018-2025)
Figure Germany Alopecia Treatment Market Forecast (2018-2025)
Figure France Alopecia Treatment Market Forecast (2018-2025)
Figure UK Alopecia Treatment Market Forecast (2018-2025)
Figure Russia Alopecia Treatment Market Forecast (2018-2025)
Figure Italy Alopecia Treatment Market Forecast (2018-2025)
Figure Rest of Europe Alopecia Treatment Market Forecast (2018-2025)
Figure Asia-Pacific Alopecia Treatment Market Forecast (2018-2025)
Figure China Alopecia Treatment Market Forecast (2018-2025)
Figure Japan Alopecia Treatment Market Forecast (2018-2025)
Figure Korea Alopecia Treatment Market Forecast (2018-2025)
Figure India Alopecia Treatment Market Forecast (2018-2025)
Figure Southeast Asia Alopecia Treatment Market Forecast (2018-2025)
Figure Rest of Asia-Pacific Alopecia Treatment Market Forecast (2018-2025)
Figure South America Alopecia Treatment Market Forecast (2018-2025)
Figure Brazil Alopecia Treatment Market Forecast (2018-2025)
Figure Argentina Alopecia Treatment Market Forecast (2018-2025)
Figure Columbia Alopecia Treatment Market Forecast (2018-2025)
Figure Rest of South America Alopecia Treatment Market Forecast (2018-2025)
Figure Middle East and Africa Alopecia Treatment Market Forecast (2018-2025)
Figure Saudi Arabia Alopecia Treatment Market Forecast (2018-2025)
Figure United Arab Emirates Alopecia Treatment Market Forecast (2018-2025)
Figure Egypt Alopecia Treatment Market Forecast (2018-2025)
Figure Nigeria Alopecia Treatment Market Forecast (2018-2025)
Figure South Africa Alopecia Treatment Market Forecast (2018-2025)
Figure Turkey Alopecia Treatment Market Forecast (2018-2025)
Figure Rest of Middle East and Africa Alopecia Treatment Market Forecast (2018-2025)
Figure Global Alopecia Treatment Forecast by Disease Type (2018-2025)
Figure Global Alopecia Treatment Market Share Forecast by Disease Type (2018-2025)
Figure Global Alopecia Treatment Forecast by Disease Type (2018-2025)
Figure Global Alopecia Treatment Forecast by Treatment Type (2018-2025)
Figure Global Alopecia Treatment Market Share Forecast by Treatment Type (2018-2025)
Figure Global Alopecia Treatment Forecast by Treatment Type (2018-2025)
Figure Global Alopecia Treatment Forecast by End User (2018-2025)
Figure Global Alopecia Treatment Market Share Forecast by End User (2018-2025)
Figure Global Alopecia Treatment Forecast by End User (2018-2025)
Please Note: Data related to the Companies are subject to Availability.
Research Methodology
We use both primary as well as secondary research for our market surveys, estimates and for developing forecast. Our research process commence by analyzing the problem which enable us to design the scope for our research study. Our research process is uniquely designed with enough flexibility to adjust according to changing nature of products and markets, while retaining core element to ensure reliability and accuracy in research findings. We understand both macro and micro-economic factors to evaluate and forecast different market segments.
Data Mining
Data is extensively collected through various secondary sources such as annual reports, investor presentations, SEC filings, and other corporate publications. We also refer trade magazines, technical journals, paid databases such as Factiva and Bloomberg, industry trade journals, scientific journals, and social media data to understand market dynamics and industry trends. Further, we also conduct primary research to understand market drivers, restraints, opportunities, challenges, and competitive scenario to build our analysis.
Data Collection Matrix
|
Data Collection Matrix |
Supply Side |
Demand Side |
|
Primary Data Sources |
|
|
|
Secondary Data Sources |
|
|
Market Modeling and Forecasting
We use epidemiology and capital equipment-based models to forecast market size of different segments at country and regional level.
- Epidemiology-based Forecasting Model: This method uses epidemiology data gathered through various publications and from physicians to estimate population of patients, flow of treatment of individual disease and therapies. The data collected through this method includes statics on incidence of disease, population suffering from disease, and treatment population. This method is used to understand:
- Number of patients for particular device or medical procedure and
- Repeated use of particular device depending on health and condition of patient
- Capital-based Forecasting Model: This method of forecasting is based on number of replacements, installed-based and new sales of capital equipment used in various healthcare and diagnostic centers. These three parameters are calculated and forecast is developed. Installation base is calculated as average number of units per facility; while sales for particular year is calculated from number of new and replace units. Secondary data is collected through various supply chain intermediaries and opinion leaders to arrive at installation and sales rate. These techniques help our analysts in validating market and developed market estimates and forecast.
We do forecast on basis of several parameters such as market drivers, market opportunities, industry trends government regulations, raw materials supply and trade dynamics to ensure relevance of forecast with market scenario. With increasing need to granulized information, we used bottom-up methodology for forecasting where we evaluate each regional segment differently and combined all forecast to develop final market forecast.
Data Validation
We believe primary research is a very important tool in analyzing and forecasting different markets. In order to make sure accuracy of our findings, our team conducts primary interviews at every stage of research to gain deep insights into current business environment and future trends and key developments in market. This includes use of various methods such as telephonic interviews, focus groups, face to face interviews and questionnaires to validate our research from all aspects. We validate our data through primary research from key industry leaders such as CEO, product managers, marketing managers, suppliers, distributors, and consumers are frequently interviewed. These interviews provide valuable insights which help us to have better market understanding besides validating our estimates and forecast.
Data Triangulation
Industry Analysis
|
Qualitative Data |
Quantitative Data (2017-2025) |
|
|